➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
Harvard Business School
Baxter
Moodys

Last Updated: October 31, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Triapine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Triapine?

Triapine is an investigational drug.

There have been 32 clinical trials for Triapine. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2002.

The most common disease conditions in clinical trials are Adenocarcinoma, Uterine Cervical Neoplasms, and Leukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), Vion Pharmaceuticals, and Cancer Therapeutics Research Group.

Recent Clinical Trials for Triapine
TitleSponsorPhase
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of HysterectomyNational Cancer Institute (NCI)Early Phase 1
Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine TumorsNational Cancer Institute (NCI)Phase 1
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar CancerNational Cancer Institute (NCI)Phase 1

See all Triapine clinical trials

Clinical Trial Summary for Triapine

Top disease conditions for Triapine
Top clinical trial sponsors for Triapine

See all Triapine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
Harvard Business School
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.